Novo Nordisk, Benefit Co. Conspired To Hike Prices, Suit Says
Drugmaker Novo Nordisk Inc. and pharmacy benefit manager OptumRx Inc. have conspired to artificially inflate the price of a Type 2 diabetes medication, forcing patients to pay more than they normally...To view the full article, register now.
Already a subscriber? Click here to view full article